Mesoblast (MESO) Priced

Developing regenerative medicine based on adult stem cells.

Health Care - Biotechnology

IPO Performance
Latest Trade $6.40 0.00 (0.0%)
First Day Return 1.4%
Return from IPO -20.0%
 
Mesoblast IPO News more
  • .
IPO Data
IPO File Date 11/02/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 7.5
Deal Size ($mm) 60
 
IPO Data
IPO Date 11/12/2015
Offer Price $8.00
Price Range $8.00 - $8.00
Offer Shares (mm) 7.5
Deal Size ($mm) $60
 
Underwriters
more
Business Overview
Developing regenerative medicine based on adult stem cells.
Developing regenerative medicine based on adult stem cells.
more
Company Data
Headquarters Melbourne, , Australia
Founded 2004
Employees 115
Website www.mesoblast.com
 

Performance vs. IPO Index (IPOUSA)